Clinical Study of Surufatinib Plus Sintilimab Combined With Chemotherapy in the Treatment of Advanced Gastric Neuroendocrine Carcinoma
Clinical trial NCT06102746 · UNKNOWN
Trial details
- NCT number
- NCT06102746
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-04-10
- Primary completion
- 2026-04-10
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.